Baxter

June 10, 2026

Labetalol and Nexterone Supply Update: What IV Cardiovascular Buyers Need to Know

Updated October 2026. FDA lists no current shortage for labetalol, amiodarone, nicardipine or diltiazem, but Baxter and Pfizer report 100 mg/20 mL labetalol constraints into 2027 and Baxter reports Nexterone 360 mg/200 mL as limited.